# Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

> **NCT07516769** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 46 (estimated)

## Conditions studied

- Rhumatoid Arthisis

## Interventions

- **DRUG:** Nicorandil 10 MG Oral Tablet

## Key facts

- **NCT ID:** NCT07516769
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-04
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516769, "Nicorandil as Anti-inflammatory in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07516769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*